Navigation Links
King Pharmaceuticals To Acquire Alpharma for Approximately $1.6 Billion
Date:11/24/2008

About ALO-01 (morphine sulfate extended-release with sequestered naltrexone hydrochloride) Capsules

ALO-01(morphine sulfate extended-release with sequestered naltrexone hydrochloride) Capsules (EMBEDA(TM)), Alpharma's product candidate currently under review with the FDA, was developed with Alpharma's proprietary technology, which combines an extended-release opioid with sequestered naltrexone, an opioid antagonist. In clinical trials, when ALO-01 Capsules were taken as directed, pain relief was provided and the sequestered naltrexone passed through the body without observed clinical effect. If an ALO-01 Capsule is crushed or dissolved in alcohol, which are common approaches abusers use to tamper with an opioid product in order to gain euphoria; both the morphine and the naltrexone are released. When both are released, study results showed that the euphoric effect of morphine was significantly reduced. EMBEDA(TM) is a proposed brand name that is subject to FDA approval.

About Special Items

Under Generally Accepted Accounting Principles ("GAAP"), reported "net earnings" and "diluted earnings per share" include special items. In addition to the reported results determined in accordance with GAAP, King provides its net earnings and diluted earnings per share results excluding special items. These non-GAAP financial measures exclude special items which are those particular material income or expense items that King considers to be unrelated to the Company's ongoing, underlying business, non-recurring, or not generally predictable. Such items include, but are not limited to, merger and restructuring expenses; non-capitalized expenses associated with acquisitions, such as in-process research and development charges and inventory valuation adjustment charges; charges resulting from the early extinguishment of debt; asset impairment charges; expenses of drug recalls; and gains and losses resultin
'/>"/>

SOURCE King Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Transdel Pharmaceuticals Appoints Mr. Lynn Swann, Pro-Football Hall of Famer, ABC Sports Broadcaster, and Former Chairman of the Presidents Council on Physical Fitness and Sports, to Board of Directors
2. Data Published in Nature Medicine Highlights Ability of Peregrine Pharmaceuticals Bavituximab to Cure Lethal Virus Infections
3. Alseres Pharmaceuticals, Inc. Announces $1 Million Financing
4. Keryx Biopharmaceuticals Receives Nasdaq Notification
5. Purdue Pharma L.P. Announces a Global Strategic Alliance With Infinity Pharmaceuticals to Advance Discovery and Development Programs in Oncology and Neuropathic Pain
6. FDA Accepts Vanda Pharmaceuticals Iloperidone Resubmission and Sets New Action Date
7. Amylin Pharmaceuticals to Present at Lazard Capital Markets Healthcare Conference
8. MiddleBrook Pharmaceuticals Reports Third Quarter 2008 Financial Results
9. MAP Pharmaceuticals Reports Third Quarter of 2008 Financial Results
10. Ferring Pharmaceuticals Promotes William Garbarini to Vice President of New Orthopaedics and Urology Business Unit
11. Alexza Pharmaceuticals Announces Upcoming Conference Participation and Webcasts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... (PRWEB) , ... July 29, 2015 , ... Wedding season is in full swing, which ... the extra pressure of looking good on the big day. Every bride wants to look ... a new level. , According to a recent study by the ...
(Date:7/29/2015)... ... , ... CanAm Enterprises, LLC (“CanAm”) is thrilled to announce that more than ... been granted to investors in four different CanAm EB-5 projects -- the Sony and ... and the Valley Forge Convention Center project in CanAm’s regional center in partnership with ...
(Date:7/29/2015)... ... 2015 , ... July is National UV Awareness Month, and in honor of this month, Dr. ... to protect skin from the sun, as well as how to best treat existing sun ... the most common skin conditions in America. Many people do not protect their skin sufficiently ...
(Date:7/29/2015)... ... July 29, 2015 , ... A June 10, 2015 article from the News-Press, ... the importance of having regular skin cancer screenings from an early age. Skin cancer ... rays. When caught early, skin cancer is rarely fatal; however, if left alone for ...
(Date:7/29/2015)... ... July 29, 2015 , ... Employee Fiduciary, LLC announces ... the general contact information, website, types of plans administered, years in business, and credentials ... and have at least one plan with Employee Fiduciary. A search can be done ...
Breaking Medicine News(10 mins):Health News:Say I Do To Surgery: Bridal Beauty On The Rise According to New Survey 2Health News:Say I Do To Surgery: Bridal Beauty On The Rise According to New Survey 3Health News:More Than 60 New I-829 Approvals in Less Than 30 days for CanAm 2Health News:More Than 60 New I-829 Approvals in Less Than 30 days for CanAm 3Health News:July is UV Awareness Month: Learn Top Tips from a Prominent Dermatologist this National UV Awareness Month 2Health News:July is UV Awareness Month: Learn Top Tips from a Prominent Dermatologist this National UV Awareness Month 3Health News:Get Checked for Skin Cancer Early and Often 2Health News:Get Checked for Skin Cancer Early and Often 3Health News:Employee Fiduciary Launches Financial Advisor Directory 2
... for Identifying E. coli, K. pneumoniae and P. ... Critical Results 24-48 Hours Sooner Than Conventional Methods ... 100,000 Patients with Gram-Negative Bloodstream InfectionsWOBURN, Mass., and ... it received FDA 510(k) clearance for EK/ P. ...
... High School Raises More than $17,000 and ... Fibrosis Foundation announced today that CW,s 7th Heaven actress ... to honor students for leading the nation in school fundraising for ... for the CureFinders (R) program for the 2008-2009 ...
... Dx Breast Cancer Profile Assists Physicians In Identifying Recurrence ... 5 Clarient, Inc. ... and molecular testing services resource for pathologists, oncologists and ... a new breast cancer test that helps physicians identify ...
... of adversity comes opportunity.” Benjamin Franklin’s significant words uttered more than ... Marrow Foundation today. , ... New York, NY (Vocus) ... significant words uttered more than 250 years ago ring true for ...
... Sleep Council and Council for Responsible Nutrition Issue Simple Steps ... 5 As stress from economic anxiety mounts, the Better ... have joined forces for Better Sleep Month in May to ... to get the best rest possible and help relieve stress, ...
... DEL MAR, Calif., May 5 ,Mayday, the ... phrase m,aider ("help me"), was appropriately celebrated this ... closed public website access to their Newsletter,s May ... Dr. Barry Friedberg, be able to document the ...
Cached Medicine News:Health News:AdvanDx Receives FDA 510(k) Clearance for EK/P. aeruginosa PNA FISH(R) 2Health News:AdvanDx Receives FDA 510(k) Clearance for EK/P. aeruginosa PNA FISH(R) 3Health News:CW's 7th Heaven Actress Mackenzie Rosman to Visit Birmingham Area High School to Honor Cystic Fibrosis Foundation Fundraising 2Health News:Clarient Launches New Breast Cancer Test 2Health News:Clarient Launches New Breast Cancer Test 3Health News:Clarient Launches New Breast Cancer Test 4Health News:Clarient Launches New Breast Cancer Test 5Health News:Clarient Launches New Breast Cancer Test 6Health News:Bone Marrow Registry to Launch Groundbreaking Fundraising Technology to Overcome Madoff Crisis 2Health News:Stress Keeps Americans Tossing and Turning 2Health News:Stress Keeps Americans Tossing and Turning 3Health News:Stress Keeps Americans Tossing and Turning 4Health News:Stress Keeps Americans Tossing and Turning 5Health News:ASA 'May Day' - Stung By Exposure of Watergate-like Public Record Deletions, American Society of Anesthesiologists Closes Access to Website Newsletter 2
(Date:7/29/2015)... PITTSBURGH , July 29, 2015 /PRNewswire/ ... it received regulatory clearance from the European Commission under ... acquisition of Perrigo Company plc (NYSE: PRGO ; ... J. Coury commented, "Today marks yet another important ... Perrigo and serves as further affirmation of the sound ...
(Date:7/29/2015)... , July 29, 2015  Efforts to improve working ... of pharmaceutical firms in North America ... is that an effective working capital management will ease ... patent cliffs. Big pharma companies expect to invest in ... Logo - http://photos.prnewswire.com/prnh/20150724/241957LOGO Analysis ...
(Date:7/29/2015)... NEW YORK and ...  CMC Biologics, a global leader in clinical ... Development Corporation (River Vision), a private company focused ... into an agreement for the process transfer and ... monoclonal antibody targeting insulin-like growth factor 1 that ...
Breaking Medicine Technology:Mylan Announces Receipt of Unconditional Clearance from European Commission on Acquisition of Perrigo 2Mylan Announces Receipt of Unconditional Clearance from European Commission on Acquisition of Perrigo 3Mylan Announces Receipt of Unconditional Clearance from European Commission on Acquisition of Perrigo 4Mylan Announces Receipt of Unconditional Clearance from European Commission on Acquisition of Perrigo 5Mylan Announces Receipt of Unconditional Clearance from European Commission on Acquisition of Perrigo 6Mylan Announces Receipt of Unconditional Clearance from European Commission on Acquisition of Perrigo 7Mylan Announces Receipt of Unconditional Clearance from European Commission on Acquisition of Perrigo 8Mylan Announces Receipt of Unconditional Clearance from European Commission on Acquisition of Perrigo 9Working Capital Management Seizes Priority in North American and European Pharma Industry 2Working Capital Management Seizes Priority in North American and European Pharma Industry 3Working Capital Management Seizes Priority in North American and European Pharma Industry 4CMC Biologics and River Vision Development Corporation Announce Manufacturing Agreement for RV001, a Monoclonal Antibody to Treat Grave's Orbitopathy 2CMC Biologics and River Vision Development Corporation Announce Manufacturing Agreement for RV001, a Monoclonal Antibody to Treat Grave's Orbitopathy 3
... 23, 2011 /PRNewswire-Asia/ -- Winner Medical Group Inc. (Nasdaq: ... a leading China-based exporter and retailer of high-quality medical ... announced that BDO China Shu Lun Pan Certified Public ... Company,s independent registered public accounting firm to replace BDO ...
... Dec. 22, 2011 ViroPharma Incorporated (NASDAQ: VPHM ... option to acquire Meritage Pharma, Inc., a private company based ... (OBS) as a treatment for eosinophilic esophagitis (EoE), a chronic ... paid an initial $7.5 million, and has agreed to provide ...
Cached Medicine Technology:Winner Medical Appoints BDO China as Independent Auditor 2ViroPharma Purchases Exclusive Option to Acquire Meritage Pharma 2ViroPharma Purchases Exclusive Option to Acquire Meritage Pharma 3ViroPharma Purchases Exclusive Option to Acquire Meritage Pharma 4ViroPharma Purchases Exclusive Option to Acquire Meritage Pharma 5ViroPharma Purchases Exclusive Option to Acquire Meritage Pharma 6ViroPharma Purchases Exclusive Option to Acquire Meritage Pharma 7
Utrata-like fine angled tips with gently curved shaft for performing capsulorhexis through tunnel incisions. Dull finish. Flat handle....
Gently curved shaft with 2 mm platform ideal for performing capsulorhexis through a tunnel incision. Flat handle with dull finish....
Straight shafts with 4 mm platform. Wide serrated handle with dull finish. Platform straight....
Straight shafts 4 mm platform. Wide serrated handle with dull finish. Platform angled 45 degrees....
Medicine Products: